Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review
- 30 September 2008
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 90 (3) , 642-672
- https://doi.org/10.1016/j.fertnstert.2007.07.1298
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Hyperhomocysteinemia, Vascular Pathology, and Endothelial DysfunctionSeminars in Thrombosis and Hemostasis, 2000
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetesThe Lancet, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- The Long-Term Effects of Oral and Transdermal Postmenopausal Hormone Replacement Therapy on Nitric Oxide, Endothelin-1, Prostacyclin, and ThromboxaneFertility and Sterility, 1998
- EFFECTS OF ESTROGEN REPLACEMENT THERAPY ON THROMBIN GENERATIONThrombosis Research, 1997
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Lipoprotein (a) : structure, properties and possible involvement in thrombogenesis and atherogenesisAtherosclerosis, 1990